[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Stevanato Group S.P.A. (STVN)

Stevanato Group S.P.A. (STVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Stevanato: Q2 Earnings Snapshot

Stevanato: Q2 Earnings Snapshot

STVN : 21.22 (-1.39%)
Stevanato Group Delivers 8% Revenue Growth for the Second Quarter of Fiscal 2026

- The Company Divests its California-Based Subsidiary, Balda C. Brewer, Inc -

STVN : 21.22 (-1.39%)
Liraglutide Combination Products Incorporating Stevanato Group's Alina® Pen Injector Received Marketing Authorizations in Multiple European Countries

The regulatory approvals cover therapies for diabetes and weight management, further expanding the commercial adoption of Stevanato Group's proprietary Alina ® pen injector platform...

STVN : 21.22 (-1.39%)
Stevanato Group to Report Second Quarter 2026 Financial Results on August 4, 2026

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced...

STVN : 21.22 (-1.39%)
Stevanato Group Introduces Deora™, a Pen Injector for Subcutaneous Delivery in Diabetes and Weight Management

The fixed-dose, multi-use pen injector platform features a pull-push mechanism designed to reduce use error while supporting delivery volumes up to 0.75 mL

STVN : 21.22 (-1.39%)
Stevanato Group Announces Results of Ordinary and Extraordinary Shareholders’ Meeting

All Resolutions Proposed to Shareholders Passed

STVN : 21.22 (-1.39%)
Stevanato: Q1 Earnings Snapshot

Stevanato: Q1 Earnings Snapshot

STVN : 21.22 (-1.39%)
Stevanato Group Delivers 7% Revenue Growth (10% at Constant Currency) for the First Quarter of Fiscal 2026

- The Company Maintains Fiscal 2026 Guidance -

STVN : 21.22 (-1.39%)
Stevanato Group to Participate in Three Upcoming Investor Conferences

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced...

STVN : 21.22 (-1.39%)
Stevanato Group to Report First Quarter 2026 Financial Results on May 7, 2026

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced...

STVN : 21.22 (-1.39%)

Barchart Exclusives

Applied Materials Stock Is Down on Earnings. Here’s What Barchart Options Data Says Could Come Next for AMAT.
Applied Materials shares sink on a Q2 revenue miss, but derivatives market believes AMAT stock will recover in the weeks ahead. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.